Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Randomized Trial of Medical versus Surgical Treatment for Refractory Heartburn.

Spechler SJ, Hunter JG, Jones KM, Lee R, Smith BR, Mashimo H, Sanchez VM, Dunbar KB, Pham TH, Murthy UK, Kim T, Jackson CS, Wallen JM, von Rosenvinge EC, Pearl JP, Laine L, Kim AW, Kaz AM, Tatum RP, Gellad ZF, Lagoo-Deenadayalan S, Rubenstein JH, Ghaferi AA, Lo WK, Fernando RS, Chan BS, Paski SC, Provenzale D, Castell DO, Lieberman D, Souza RF, Chey WD, Warren SR, Davis-Karim A, Melton SD, Genta RM, Serpi T, Biswas K, Huang GD.

N Engl J Med. 2019 Oct 17;381(16):1513-1523. doi: 10.1056/NEJMoa1811424.

PMID:
31618539
3.

Dexlansoprazole is Effective in Relieving Heartburn during the Fasting Month of Ramadan.

Rimmani HH, Rustom LBO, Rahal MA, Shayto RH, Chaar H, Sharara AI.

Dig Dis. 2019;37(3):188-193. doi: 10.1159/000496091. Epub 2019 Jan 9.

PMID:
30625462
4.

Randomised clinical trial: vonoprazan versus lansoprazole for the initial relief of heartburn in patients with erosive oesophagitis.

Oshima T, Arai E, Taki M, Kondo T, Tomita T, Fukui H, Watari J, Miwa H.

Aliment Pharmacol Ther. 2019 Jan;49(2):140-146. doi: 10.1111/apt.15062.

PMID:
30589965
5.

Revisiting Montreal: New Insights into Symptoms and Their Causes, and Implications for the Future of GERD.

Hungin APS, Molloy-Bland M, Scarpignato C.

Am J Gastroenterol. 2019 Mar;114(3):414-421. doi: 10.1038/s41395-018-0287-1. Review.

6.

Gastro-oesophageal fistula in an achalasia patient following myotomy as an unusual cause of heartburn.

Falk GL, Little SC.

Ann R Coll Surg Engl. 2019 Feb;101(2):e35-e37. doi: 10.1308/rcsann.2018.0179. Epub 2018 Oct 5.

PMID:
30286658
7.

Randomized clinical trial: a double-blind, placebo-controlled study to assess the clinical efficacy and safety of alginate-antacid (Gaviscon Double Action) chewable tablets in patients with gastro-oesophageal reflux disease.

Wilkinson J, Wade A, Thomas SJ, Jenner B, Hodgkinson V, Coyle C.

Eur J Gastroenterol Hepatol. 2019 Jan;31(1):86-93. doi: 10.1097/MEG.0000000000001258.

PMID:
30272584
8.

Pilot, Randomized, Blinded, Placebo-Controlled Trial Investigating the Correlation Between Acid Control and Heartburn Relief with 14 Days of Esomeprazole Treatment.

Miner PB, Johnson DA, Katz PO, Li J, Gatoulis SC, Pollack C.

Adv Ther. 2018 Nov;35(11):2024-2040. doi: 10.1007/s12325-018-0792-z. Epub 2018 Sep 25.

9.

Prospective Single Arm Study on the Effect of Ilaprazole in Patients with Heartburn but No Reflux Esophagitis.

Song IJ, Kim HK, Lee NK, Lee SK.

Yonsei Med J. 2018 Oct;59(8):951-959. doi: 10.3349/ymj.2018.59.8.951.

10.

Convenient Method of Measuring Baseline Impedance for Distinguishing Patients with Functional Heartburn from those with Proton Pump Inhibitor-Resistant Endoscopic Negative Reflux Disease.

Yoshimine T, Funaki Y, Kawamura Y, Tamura Y, Izawa S, Ebi M, Ogasawara N, Murotani K, Sasaki M, Kasugai K.

Digestion. 2019;99(2):157-165. doi: 10.1159/000490790. Epub 2018 Sep 4.

PMID:
30179879
11.

Model to Select On-Therapy vs Off-Therapy Tests for Patients With Refractory Esophageal or Extraesophageal Symptoms.

Patel DA, Sharda R, Choksi YA, Slaughter JC, Higginbotham T, Garrett CG, Francis DO, Ravi K, Hasak S, Katzka D, Gyawali CP, Vaezi MF.

Gastroenterology. 2018 Dec;155(6):1729-1740.e1. doi: 10.1053/j.gastro.2018.08.038. Epub 2018 Aug 28.

PMID:
30170117
12.

Optimal Omeprazole Dosing and Symptom Control: A Randomized Controlled Trial (OSCAR Trial).

Waghray A, Waghray N, Perzynski AT, Votruba M, Wolfe MM.

Dig Dis Sci. 2019 Jan;64(1):158-166. doi: 10.1007/s10620-018-5235-9. Epub 2018 Aug 9.

PMID:
30094626
13.

Treating Gastroesophageal Reflux and Heartburn While Breastfeeding.

Anderson PO.

Breastfeed Med. 2018 Sep;13(7):463-464. doi: 10.1089/bfm.2018.0124. Epub 2018 Aug 3. Review. No abstract available.

PMID:
30074826
14.

Gamma-aminobutyric acid receptor type B agonist baclofen inhibits acid-induced excitation of secondary peristalsis but not heartburn sensation.

Wong MW, Hung JS, Liu TT, Yi CH, Lei WY, Chen CL.

J Gastroenterol Hepatol. 2019 Feb;34(2):370-375. doi: 10.1111/jgh.14404. Epub 2018 Aug 16.

PMID:
30069912
15.

Use of Esophageal pH Monitoring to Minimize Proton-Pump Inhibitor Utilization in Patients with Gastroesophageal Reflux Symptoms.

Triadafilopoulos G, Zikos T, Regalia K, Sonu I, Fernandez-Becker NQ, Nguyen L, Nandwani MCR, Clarke JO.

Dig Dis Sci. 2018 Oct;63(10):2673-2680. doi: 10.1007/s10620-018-5183-4. Epub 2018 Jun 29.

PMID:
29959725
16.

Pathogenesis of Potassium-Competitive Acid Blocker-Resistant Non-Erosive Reflux Disease.

Kawami N, Hoshino S, Hoshikawa Y, Takenouchi N, Umezawa M, Hanada Y, Kaise M, Iwakiri K.

Digestion. 2018;98(3):194-200. doi: 10.1159/000488530. Epub 2018 Jun 5.

PMID:
29870976
17.
18.

An Unusual Case of Heartburn and Esophageal Stenosis.

Fernández-Aceñero MJ, Riesco JM, Campos R.

Dysphagia. 2018 Oct;33(5):725-727. doi: 10.1007/s00455-018-9910-y. Epub 2018 May 21. No abstract available.

PMID:
29785680
19.

Management of Patients With Functional Heartburn.

Lee YY, Wu JCY.

Gastroenterology. 2018 Jun;154(8):2018-2021.e1. doi: 10.1053/j.gastro.2018.04.030. Epub 2018 May 3. No abstract available.

PMID:
29730025
20.

Lack of improvement of impaired chemical clearance characterizes PPI-refractory reflux-related heartburn.

Frazzoni M, Frazzoni L, Tolone S, De Bortoli N, Savarino V, Savarino E.

Am J Gastroenterol. 2018 May;113(5):670-676. doi: 10.1038/s41395-018-0044-5. Epub 2018 Apr 23.

PMID:
29681623

Supplemental Content

Loading ...
Support Center